港股異動丨知行科技漲超6% 成立附屬"艾摩星機器人" 積極佈局機器人、具身智能及相關領域
知行科技(1274.HK)今日盤中一度漲6.1%至19.12港元。知行科技公告,公司已於江蘇省蘇州市成立一間全資附屬公司,該附屬公司稱爲"艾摩星機器人(蘇州)有限公司"。作爲國內領先的量產自動駕駛解決方案提供商,公司計劃通過技術複用、產業鏈協同和生態構建,積極佈局機器人、具身智能及相關領域。公司設立機器人全資附屬公司探索機器人業務多場景應用落地,推動"AI+汽車+機器人"的跨界融合佈局。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.